296 related articles for article (PubMed ID: 29020486)
1. Ocular Manifestations and Visual Outcomes of Behçet's Uveitis in a Thai population.
Pathanapitoon K; Kunavisarut P; Saravuttikul FA; Rothova A
Ocul Immunol Inflamm; 2019; 27(1):2-6. PubMed ID: 29020486
[TBL] [Abstract][Full Text] [Related]
2. Combination of pulse cyclophosphamide and azathioprine in ocular manifestations of Behcet's disease: longitudinal study of up to 10 years.
Davatchi F; Sadeghi Abdollahi B; Shams H; Shahram F; Nadji A; Chams-Davatchi C; Faezi T; Akhlaghi M; Ghodsi Z; Ashofteh F; Mohtasham N
Int J Rheum Dis; 2014 May; 17(4):444-52. PubMed ID: 24314325
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate in ocular manifestations of Behcet's disease: a longitudinal study up to 15 years.
Davatchi F; Shams H; Shahram F; Nadji A; Chams-Davatchi C; Sadeghi Abdollahi B; Faezi T; Akhlaghi M; Ashofteh F
Int J Rheum Dis; 2013 Oct; 16(5):568-77. PubMed ID: 24164845
[TBL] [Abstract][Full Text] [Related]
4. Azathioprine and low dose pulse cyclophosphamide in severe ocular lesions of Behçet's disease. A preliminary report.
Shahram F; Davatchi F; Chams H; Nadji A; Jamshidi A; Akbarian M; Gharibdoost F
Adv Exp Med Biol; 2003; 528():571-3. PubMed ID: 12918767
[No Abstract] [Full Text] [Related]
5. Pattern of uveitis in Behçet's disease in a referral center in Tunisia, North Africa.
Khairallah M; Attia S; Yahia SB; Jenzeri S; Ghrissi R; Jelliti B; Zaouali S; Messaoud R
Int Ophthalmol; 2009 Jun; 29(3):135-41. PubMed ID: 18365145
[TBL] [Abstract][Full Text] [Related]
6. Pattern and causes of visual loss in Behçet's uveitis: short-term and long-term outcomes.
Amer R; Alsughayyar W; Almeida D
Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1423-1432. PubMed ID: 28396946
[TBL] [Abstract][Full Text] [Related]
7. Rituximab in intractable ocular lesions of Behcet's disease; randomized single-blind control study (pilot study).
Davatchi F; Shams H; Rezaipoor M; Sadeghi-Abdollahi B; Shahram F; Nadji A; Chams-Davatchi C; Akhlaghi M; Faezi T; Naderi N
Int J Rheum Dis; 2010 Aug; 13(3):246-52. PubMed ID: 20704622
[TBL] [Abstract][Full Text] [Related]
8. [Ocular manifestations of Behçet's disease].
Saadouli D; Lahmar A; Ben Mansour K; El Afrit N; Yahyaoui S; El Afrit MA
J Fr Ophtalmol; 2021 Feb; 44(2):196-202. PubMed ID: 33380351
[TBL] [Abstract][Full Text] [Related]
9. Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis.
Kötter I; Zierhut M; Eckstein AK; Vonthein R; Ness T; Günaydin I; Grimbacher B; Blaschke S; Meyer-Riemann W; Peter HH; Stübiger N
Br J Ophthalmol; 2003 Apr; 87(4):423-31. PubMed ID: 12642304
[TBL] [Abstract][Full Text] [Related]
10. High-dose intravenous steroid pulse therapy in ocular involvement of Behcet's disease: a pilot double-blind controlled study.
Mohammadi M; Shahram F; Shams H; Akhlaghi M; Ashofteh F; Davatchi F
Int J Rheum Dis; 2017 Sep; 20(9):1269-1276. PubMed ID: 28524639
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of TNF-alpha antagonist and other immunomodulators in the treatment of patients with ophthalmologic manifestations of Behcet's disease and HLA B51 positive vasculitis].
Zlatanović G; Jovanović S; Veselinović D; Zivković M
Vojnosanit Pregl; 2012 Feb; 69(2):168-74. PubMed ID: 22500372
[TBL] [Abstract][Full Text] [Related]
12. High dose methotrexate for ocular lesions of Behçet's disease. Preliminary short-term results.
Davatchi F; Shahram F; Chams H; Jamshidi AR; Nadji A; Chams C; Akbarian M; Gharibdoost F
Adv Exp Med Biol; 2003; 528():579-84. PubMed ID: 12918769
[No Abstract] [Full Text] [Related]
13. [Clinical features of patients with Behcet's uveitis].
Liu XS; Gao F; Zhao C; Zhang MF
Zhonghua Yan Ke Za Zhi; 2020 Mar; 56(3):217-223. PubMed ID: 32187951
[No Abstract] [Full Text] [Related]
14. Ocular Manifestations, Conventional Fundus Fluorescein Angiographic Findings, and Relationship Between Angiographic Findings and Visual Acuity in Behçet's Disease.
Bazvand F; Zarei M; Ebrahimiadib N; Karkhaneh R; Davoudi S; Soleimanzadeh M; Sharifian E; Roohipoor R; Modjtahedi BS
Semin Ophthalmol; 2017; 32(6):764-771. PubMed ID: 27715380
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of Behçet's disease in the Indian population.
Sachdev N; Kapali N; Singh R; Gupta V; Gupta A
Int Ophthalmol; 2009 Dec; 29(6):495-501. PubMed ID: 18936879
[TBL] [Abstract][Full Text] [Related]
16. Ocular Manifestations in Late Onset Behçet's Disease.
Saadouli D; Mansour KB; Yahyaoui S; Afrit NE; Lahmar A; Afrit AE
Curr Aging Sci; 2021; 14(1):56-61. PubMed ID: 31994475
[TBL] [Abstract][Full Text] [Related]
17. Eye and Behçet's disease.
Ksiaa I; Abroug N; Kechida M; Zina S; Jelliti B; Khochtali S; Attia S; Khairallah M
J Fr Ophtalmol; 2019 Apr; 42(4):e133-e146. PubMed ID: 30850197
[TBL] [Abstract][Full Text] [Related]
18. Gender influence on ocular manifestations and their outcome in Behcet's Disease. A long-term follow-up of up to 20 years.
Davatchi F; Shahram F; Shams H; Nadji A; Chams-Davatchi C; Akhlaghi M; Faezi ST; Ashofteh F; Sadeghi-Abdollahi B
Clin Rheumatol; 2011 Apr; 30(4):541-7. PubMed ID: 20857156
[TBL] [Abstract][Full Text] [Related]
19. Childhood-onset uveitis in Behçet disease:a descriptive study of 36 cases.
Tugal-Tutkun I; Urgancioglu M
Am J Ophthalmol; 2003 Dec; 136(6):1114-9. PubMed ID: 14644223
[TBL] [Abstract][Full Text] [Related]
20. [Eye and Behçet's disease].
Ksiaa I; Abroug N; Kechida M; Zina S; Jelliti B; Khochtali S; Attia S; Khairallah M
J Fr Ophtalmol; 2019 Jun; 42(6):626-641. PubMed ID: 31164292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
